ZIM
NEO icon

ZPR Investment Management’s NeoGenomics NEO Stock Holding History

ZPR Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,948
Closed -$61K – 46
2013
Q4 		$61K Buy
+16,948
New +$58.8K 0.07% 40

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

ZPR Investment Management's NEO Position: Q1 2014 in Review

ZPR Investment Management sold out of NeoGenomics (NEO) in Q1 2014, closing a stake of 16,948 shares — an estimated $61K sold.

ZPR Investment Management first reported a position in NEO in Q4 2013 and held it in 1 quarter. The position peaked at $61K in Q4 2013. 69 funds tracked by Wall St. Rank hold NEO as of Q1 2014.

  • ZPR Investment Management reported no remaining NeoGenomics position as of Q1 2014 after selling out during the quarter.
  • ZPR Investment Management sold 16,948 NeoGenomics shares in Q1 2014, an estimated $61K.
  • ZPR Investment Management first reported a position in NeoGenomics in Q4 2013 and held it in 1 quarter.
  • ZPR Investment Management's NeoGenomics position peaked at $61K in Q4 2013.
  • 69 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2014.

Based on ZPR Investment Management's 13F filing for Q1 2014, filed 15 May 2014.